Novel discovery improves profiling of acute myeloid leukemia patients for targeted therapies

Researchers have identified a set of genes, including DNMT3A, that could potentially be used to predict clinical outcomes of patients who suffer from a type of Acute Myeloid Leukemia (AML) associated with an FLT3 internal tandem duplication (FLT3-ITD) mutation.

Read the whole article on Science Daily

More from Science Daily